Zsuzsanna Kürti - Data sheet of PhD student


	Login Forum Organisation officers member institutions resolutions (in Hung.) by-laws (in Hung.) regulations Doctoral program doctoral schools by institution by research field by number ceased working academic staff member by name by research topic archives thesis topic proposals by doctoral school by research field by research topic supervision of PhD students search students Theses defended by institution by research field by name by date by doctoral school Naturalized degrees by institution by research field by name by date Habilitation presentations by institution by branch of science by name Documents (all in Hung.) public documents news legal backgrounds guidelines Contacts contact details partners

Data sheet of PhD student

Print preview

Personal data

name	Zsuzsanna Kürti
name of institution	Semmelweis University, Budapest
doctoral school	SE Károly Rácz Doctoral School of Clinical Medicine

Supervision
thesis supervisor	Péter László Lakatos
one supervisor or with co-supervisor	individual
degree	PhD
starting of doctoral studies	2015
date of final certificate (year,month)	2018/08
year in which degree was obtained	2019
diszertáció	Main findings in the thesis (in Hungarian)Main findings in the thesis (in English)The thesis
data of the public discussion	defense

Publications

2017

Gonczi L, Vegh Z, Golovics PA, Rutka M, Gecse KB, Bor R, Farkas K, Szamosi T, Bene L, Gasztonyi B, Kristóf T, Lakatos L, Miheller P, Palatka K, Papp M, Patai A, Salamon A, Tóth GT, Vincze A, Biro E, Lovasz BD, Kurti Z, Szepes Z, Molnár T, Lakatos PL: Prediction of short- and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play a more important role?, JOURNAL OF CROHNS & COLITIS 11: (6) pp. 697-705.
type of document: Journal paper/Article
language: English
URL

2017

Gonczi L, Kurti Z, Rutka M, Vegh Z, Farkas K, Lovasz BD, Golovics PA, Gecse KB, Szalay B, Molnar T, Lakatos PL: Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases, BMC GASTROENTEROLOGY 17: (1) Paper 97. p.
type of document: Journal paper/Article
language: English
URL

2016

Kurti Z, Vegh Z, Golovics PA, Fadgyas-Freyler P, Gecse KB, Gonczi L, Gimesi-Orszagh J, Lovasz BD, Lakatos PL: Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database, DIGESTIVE AND LIVER DISEASE 48: (11) pp. 1302-1307.
type of document: Journal paper/Article
number of independent citations: 1
language: English
DOI

2015

Kurti Z, Lovasz BD, Mandel MD, Csima Z, Golovics PA, Csako BD, Mohas A, Gonczi L, Gecse KB, Kiss LS, Szathmari M, Lakatos PL: The burden of Clostridium difficile infection between 2010 and 2013: trends and outcomes from an academic center in Eastern Europe, WORLD JOURNAL OF GASTROENTEROLOGY 21: (21) pp. 6728-6735.
type of document: Journal paper/Article
number of independent citations: 6
language: English
URL

2015

Kurti Z, Lovasz BD, Gecse KG, Balint A, Farkas K, Morocza-Szabo A, Gyurcsanyi A, Kristof K, Vegh Z, Gonczi L, Kiss LS, Golovics PA, Lakatos L, Molnar T, Lakatos PL: Tuberculin skin test and Quantiferon in BCG vaccinated; immunosuppressed patients with moderate-to-severe inflammatory bowel disease, JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES 24: (4) pp. 467-472.
type of document: Journal paper/Article
number of independent citations: 2
language: English
DOI

Number of independent citations to these publications:

Scientometric data

list of publications and citations

number of scientific publications that meet accreditation criteria:

number of scientific publications:

monographs and professional books:

monographs/books in which chapters/sections were contributed:

number of independent citations to scientific publications and creative works:

Research
research area	A gyulladásos bélbetegségek epidemiológiája, klinikuma és a betegség progresszióját meghatározó klinikai tényezők és biomarkerek (to be translated)
research field in which current research is conducted	general health sciences

2024. IV. 17.
ODT ülés
Az ODT következő ülésére 2024. június 14-én, pénteken 10.00 órakor kerül sor a Semmelweis Egyetem Szenátusi termében (Bp. Üllői út 26. I. emelet).